Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in mend™, a multimodal wellness company that pairs evidence-based, scientifically-backed nutritional supplements with a digital platform to augment healing and chronic condition management. Mend provides supplements with a demonstrated ability to improve peri-operative recovery and modifiable risk factors, along with a digital platform that supports patient engagement and communication with the care team.
Kelly Boyer, Vice President of Film Coatings at Colorcon, said, “mend is aligned with Colorcon Ventures’ interest in expanding the market opportunities for nutritional supplements. Their emphasis on scientific validation and digital engagement will allow them to enhance outcomes in the acute care setting, while continuing to support healthy, active lives outside of the hospital setting. We look forward to supporting mend as they realize the full potential of their platform.”
Eziah Syed, mend’s CEO, said, “We are glad to have the support of Colorcon Ventures as we grow our business and bring our nutritional solutions into the healthcare ecosystem. Colorcon’s formulation expertise will help streamline our product development and accelerate our next phase of growth.”
Colorcon Ventures joins a prominent list of investors who also participated in mend’s recently announced Series A, including S2G Ventures, GenHenn Capital, Keen Growth Capital, Tech Council Ventures and others.
